{
    "eid": "2-s2.0-85064315484",
    "title": "Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II",
    "cover-date": "2020-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acute coronary syndrome",
        "Cholesterol",
        "Ezetimibe",
        "Hyperlipidaemia",
        "Statins"
    ],
    "authors": [
        "Wacin Buddhari",
        "Preecha Uerojanaungkul",
        "Charn Sriratanasathavorn",
        "Apichard Sukonthasarn",
        "Baishali Ambegaonkar",
        "Philippe Brudi",
        "Martin Horack",
        "Dominik Lautsch",
        "Ami Vyas",
        "Anselm K. Gitt"
    ],
    "citedby-count": 2,
    "ref-count": 37,
    "ref-list": [
        "Cardiovascular disease epidemiology in Asia: an overview",
        "Estimated causes of death in Thailand, 2005: implications for health policy",
        "Risk factors for cardiovascular disease mortality among 86866 members of the Thai Cohort Study, 2005\u20132010",
        "Cholesterol, coronary heart disease, and stroke in the Asia Pacific region",
        "Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins",
        "2016 ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)",
        "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines",
        "2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult",
        "Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version",
        "Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal <70 mg/dL: a real-life cohort in a developing country",
        "Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients",
        "Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey",
        "Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey",
        "Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II",
        "Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II",
        "Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan \u2013 findings from the Dyslipidemia International Study II",
        "ESC Committee for Practice Guidelines (CPG) 2008\u20132010 and 2010\u20132012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)",
        "A systematic review and meta-analysis on the therapeutic equivalence of statins",
        "Thai Registry in Acute Coronary Syndrome (TRACS) \u2013 an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year",
        "Coronary artery disease in the Thai population: data from health situation analysis 2010",
        "Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic",
        "Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction",
        "Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand Study",
        "Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009",
        "Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study",
        "Statin pretreatment and presentation patterns in patients with coronary artery disease",
        "Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol",
        "Update on the efficacy of statin treatment in acute coronary syndromes",
        "Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy)",
        "Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS)",
        "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials",
        "The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials",
        "Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction",
        "Ezetimibe added to statin therapy after acute coronary syndromes",
        "Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy",
        "Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial",
        "Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: a 6-year population-based cohort study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Piscataway",
            "@id": "60082106",
            "affilname": "Rutgers School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082106",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ludwigshafen",
            "@id": "60022960",
            "affilname": "Klinikum Ludwigshafen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022960",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Rahway",
            "@id": "60007995",
            "affilname": "Merck &amp; Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ludwigshafen",
            "@id": "100527874",
            "affilname": "Stiftung Institut f\u00fcr Herzinfarktforschung",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100527874",
            "affiliation-country": "Germany"
        }
    ],
    "funding": [
        "Merck & Co"
    ]
}